Your session is about to expire
← Back to Search
Genomic Risk Assessment for Genetic Disorders (eMERGE Trial)
eMERGE Trial Summary
This trial will test a new method to identify people at high risk for specific diseases and recommend individualized approaches to prevention and care.
eMERGE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria beloweMERGE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.eMERGE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 3 and 17 years old.I have not had a transplant or transfusion in the last 8 weeks.I am between 18 and 75 years old.I am between 3 and 17 years old.I am between 18 and 75 years old.I am unable to give consent for medical procedures.You are able to provide a healthcare provider or clinician to receive results.
- Group 1: Participants receiving a Genome Informed Risk Assessment (GIRA)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor open to individuals who have surpassed their diamond jubilee?
"This experiment has an age range specification of 3 to 75 years old, which defines the minimum and maximum eligibility requirements."
How many participants are involved in this clinical venture?
"To be successful, this clinical trial needs to enroll 25000 eligible applicants. Potential participants can find sites offering the study in cities such as Boston and Birmingham. Specifically, Massachusetts General Hospital in Boston and University of Alabama Birmingham are two options for enrolment."
Is this trial accessible to patients in North America through multiple locations?
"Massachusetts General Hospital in Boston, University of Alabama Birmingham in Birmigham, and Mount Sinai in New york are three sites actively enrolling patients for this trial. Additionally, 12 other medical centres across the country have been added to the recruitment list."
Is recruitment open for this trial?
"As per information available on clinicaltrials.gov, this experiment is actively looking for enrollees. It was first introduced to the public on February 16th 2022 and most recently updated on October 14th of that same year."
Am I eligible to be part of this trial?
"For consideration in this medical study, participants must have a genetic disorder and be aged between 3 to 75. Currently, the team is actively recruiting 25 000 individuals for the trial."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger